<DOC>
	<DOCNO>NCT01642537</DOCNO>
	<brief_summary>The purpose study feasibility study Rhythmia Medical Mapping System Mapping Catheter patient undergo catheter ablation procedure treatment cardiac tachyarrhythmias .</brief_summary>
	<brief_title>Electroanatomical Mapping Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System Catheter</brief_title>
	<detailed_description />
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>1 . Patient understands implication participate study provide informed consent 2 . Patient willing comply specify followup evaluation contact telephone 3 . Patients refer catheter ablation procedure treat atrial ventricular arrhythmia 4 . Patient heparinized procedure 1 . Patients require emergency ablation procedure 2 . Patients hemodynamically unstable 3 . Patients NYHA Class III IV heart failure 4 . Women pregnant lactate 5 . Patients cardiac surgery within past two month 6 . Patients Long QT Syndrome , Brugada Syndrome , Torsade de Pointes 7 . Patients intracardiac thrombus , tumor , abnormality precludes catheter introduction 8 . Patients acute myocardial infarction within 3 month 9 . Patients await cardiac transplantation 10 . Patients enrol clinical study 11 . Patients age &lt; 18 &gt; 75 year 12 . Patients stable/unstable angina ongoing myocardial ischemia 13 . Patients congenital heart disease ( include atrial septal defect ( ASD ) patent foramen ovale ( PFO ) without right leave shunt ) underlie abnormality increase risk ablative procedure 14 . Patients pulmonary hypertension ( mean systolic pulmonary artery ( PA ) pressure &gt; 50mm Hg Doppler echo ) 15 . Patients leave atrial diameter &gt; 55 mm 16 . Patients arrhythmia currently treat arrhythmia management may interfere study 17 . Patients active infection sepsis 18 . Patients untreatable allergy contrast medium 19 . Patients history blood clotting ( bleed thrombotic ) abnormalities 20 . Patients known sensitivity heparin warfarin 21 . Patients severe chronic obstructive pulmonary disease ( COPD ) ( identify force expiratory volume [ FEV1 ] &lt; 1 ) 22 . Patients severe co morbidity poor general physical/mental health , opinion investigator , allow patient good study candidate ( i.e . disease process , mental capacity , substance abuse , shorten life expectance , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>